 |
|
Home | Neurocrine Biosciences CEO Kevin Charles Gorman Unloads 108,000 Shares (NBIX) |
 |
Neurocrine Biosciences CEO Kevin Charles Gorman Unloads 108,000 Shares (NBIX)
|
 |
- January 08, 2014
-
Neurocrine Biosciences (NASDAQ:NBIX) CEO Kevin Charles Gorman sold 108,000 shares of the company’s stock in a transaction dated Tuesday, January 7th. The stock was sold at an average price of $16.76, for a total value of $1,810,080.00. Following the transaction, the chief executive officer now directly owns 177,202 shares of the company’s stock, valued at […]This article (Neurocrine Biosciences CEO Kevin Charles Gorman Unloads 108,000 Shares (NBIX)) was originally developed by and is property of American Banking News.
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
- Read more at:http://www.americanbankingnews.com/2014/01/08/neurocrine-biosciences-ceo-kevin-charles-gorman-unloads-108000-shares-nbix/
|
 |
|
 |
|
 |
